بوليتكنك فلسطين والمجمع الطبي العربي يوقّعان مذكرة تفاهم لإنشاء مجمع العزة الطبي alwatanvoice.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from alwatanvoice.com Daily Mail and Mail on Sunday newspapers.
BRUSSELS, Jan. 12 (Xinhua) The European Medicines Agency (EMA) said on Tuesday it had received the application for conditional marketing authorization for a
The Sindh High Court has directed the health department to submit a report on the progress made in finalising standard operating procedures to improve the medico-legal system of the province.The.
(2)
COPENHAGEN, Denmark, Jan. 13, 2021 /PRNewswire/ IO Biotech, a clinical-stage biopharmaceutical company developing novel, immune-modulating anti-cancer therapies based on its proprietary T-win technology, announced today that it has raised EUR 127 million in Series B financing. The financing round was led by HBM Healthcare Investments, and other new investors joining the round included Vivo Capital, Kurma Partners, Avoro Capital, RA Capital Management, Samsara Biocapital, Idinvest Partners
1, PFM Health Sciences, Soleus Capital, Eir Ventures and Serrado Capital, with the participation of existing investors Novo Seeds, Lundbeckfonden Emerge and Sunstone Life Science Ventures. Additionally, Dr. Priyanka Belawat of HBM Partners, Jack B. Nielsen of Vivo Capital and Vanessa Malier of Kurma Partners will join IO Biotech s board of directors as part of the closing of the financing.
MedCity News
Andy Slavitt at JPM: Biden unlikely to pick ‘divisive’ fights on healthcare
In a wide-ranging discussion at J.P. Morgan s Annual Healthcare Conference, former CMS Administrator Andy Slavitt talked about the future of the ACA, telehealth and Medicare Advantage with a Democrat-led House, Senate and presidency.
Shares1
For the first time in more than a decade, healthcare will not be a big first-term agenda item for Congress, and instead, those picked to run federal healthcare agencies will have a degree of latitude on what pieces of the healthcare puzzle they decide to focus on.
That’s the message from Andy Slavitt, former acting administrator of the Centers for Medicare and Medicaid, who was speaking at the all-virtual 39th J.P. Morgan Healthcare Conference.